Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

DNA Repair Molecular Beacon assay: a platform for real-time functional analysis of cellular DNA repair capacity.

Li J, Svilar D, McClellan S, Kim JH, Ahn EE, Vens C, Wilson DM 3rd, Sobol RW.

Oncotarget. 2018 Aug 3;9(60):31719-31743. doi: 10.18632/oncotarget.25859. eCollection 2018 Aug 3.

2.

HSP90 regulates DNA repair via the interaction between XRCC1 and DNA polymerase β.

Fang Q, Inanc B, Schamus S, Wang XH, Wei L, Brown AR, Svilar D, Sugrue KF, Goellner EM, Zeng X, Yates NA, Lan L, Vens C, Sobol RW.

Nat Commun. 2014 Nov 26;5:5513. doi: 10.1038/ncomms6513.

3.

SMUG1 but not UNG DNA glycosylase contributes to the cellular response to recovery from 5-fluorouracil induced replication stress.

Nagaria P, Svilar D, Brown AR, Wang XH, Sobol RW, Wyatt MD.

Mutat Res. 2013 Mar-Apr;743-744:26-32. doi: 10.1016/j.mrfmmm.2012.12.001. Epub 2012 Dec 17.

4.

Synthesis and characterization of DNA minor groove binding alkylating agents.

Iyer P, Srinivasan A, Singh SK, Mascara GP, Zayitova S, Sidone B, Fouquerel E, Svilar D, Sobol RW, Bobola MS, Silber JR, Gold B.

Chem Res Toxicol. 2013 Jan 18;26(1):156-68. doi: 10.1021/tx300437x. Epub 2012 Dec 26.

5.

Alkylation sensitivity screens reveal a conserved cross-species functionome.

Svilar D, Dyavaiah M, Brown AR, Tang JB, Li J, McDonald PR, Shun TY, Braganza A, Wang XH, Maniar S, St Croix CM, Lazo JS, Pollack IF, Begley TJ, Sobol RW.

Mol Cancer Res. 2012 Dec;10(12):1580-96. doi: 10.1158/1541-7786.MCR-12-0168. Epub 2012 Oct 4.

6.
7.

Targeting DNA polymerase ß for therapeutic intervention.

Goellner EM, Svilar D, Almeida KH, Sobol RW.

Curr Mol Pharmacol. 2012 Jan;5(1):68-87. Review.

8.

XRCC1 and base excision repair balance in response to nitric oxide.

Mutamba JT, Svilar D, Prasongtanakij S, Wang XH, Lin YC, Dedon PC, Sobol RW, Engelward BP.

DNA Repair (Amst). 2011 Dec 10;10(12):1282-93. doi: 10.1016/j.dnarep.2011.10.008. Epub 2011 Oct 29.

9.

Methods for measuring acoustic power of an ultrasonic neurosurgical device.

Petosić A, Ivancević B, Svilar D, Stimac T, Paladino J, Oresković D, Jurjević I, Klarica M.

Coll Antropol. 2011 Jan;35 Suppl 1:107-13.

PMID:
21648319
10.

N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide.

Tang JB, Svilar D, Trivedi RN, Wang XH, Goellner EM, Moore B, Hamilton RL, Banze LA, Brown AR, Sobol RW.

Neuro Oncol. 2011 May;13(5):471-86. doi: 10.1093/neuonc/nor011. Epub 2011 Mar 3.

11.

Comparison of measured acoustic power results gained by using three different methods on an ultrasonic low-frequency device.

Petosić A, Svilar D, Ivancević B.

Ultrason Sonochem. 2011 Mar;18(2):567-76. doi: 10.1016/j.ultsonch.2010.08.005. Epub 2010 Aug 19.

PMID:
20850368
12.

Base excision repair and lesion-dependent subpathways for repair of oxidative DNA damage.

Svilar D, Goellner EM, Almeida KH, Sobol RW.

Antioxid Redox Signal. 2011 Jun 15;14(12):2491-507. doi: 10.1089/ars.2010.3466. Epub 2010 Oct 28. Review.

13.

Bioenergetic metabolites regulate base excision repair-dependent cell death in response to DNA damage.

Tang JB, Goellner EM, Wang XH, Trivedi RN, St Croix CM, Jelezcova E, Svilar D, Brown AR, Sobol RW.

Mol Cancer Res. 2010 Jan;8(1):67-79. doi: 10.1158/1541-7786.MCR-09-0411. Epub 2010 Jan 12.

14.

Measuring derived acoustic power of an ultrasound surgical device in the linear and nonlinear operating modes.

Petosić A, Ivancević B, Svilar D.

Ultrasonics. 2009 Jun;49(6-7):522-31. doi: 10.1016/j.ultras.2009.01.002. Epub 2009 Jan 16.

PMID:
19217636

Supplemental Content

Loading ...
Support Center